Fairvalue-Calculator Fairvalue-Calculator
EN DE

Coreline Soft Co (384470) Fair Value & Analysis

Healthcare · KR · Market cap 63.9B KRW

Price3,000 KRW
Fair Value3,038 KRW
Upside+1.3%
Quality95/100
Evidence: Low Range 2,278 KRW – 3,797 KRW

Fair value as of: Jun 24, 2026

Analysis

Coreline Soft Co (384470) currently trades at 3,000 KRW, while our model-based Fair Value estimate is 3,038 KRW — implying the stock looks roughly 1.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Coreline Soft Co., Ltd. develops medical software to provide diagnosis and image solution for lung diseases. It offers AVIEW Metric-Lung, a quantitative image biomarker software of COPD using chest CT images; AVIEW Modeler, a three-dimensional (3D) modeling software for 3D printing; and AVIEW Research, a software for medical research data management. The company was founded in 2012 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -56% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -53% Lonza Group (LZAGY) -74% Agilent Technologies, Inc (A) -50%

Frequently asked questions

Is Coreline Soft Co (384470) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 3,038 KRW versus a price of 3,000 KRW — about +1% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 384470?
Our 21-model fair value for Coreline Soft Co is 3,038 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 3,000 KRW.
What is the quality score of 384470?
Coreline Soft Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.